NEWS
You can follow the latest news of MicroViable in this section
Microviable participates in a research that has demonstrated that certain microbiota bacteria can be used as new probiotics to improve physical performance.
The work, led by a joint IPLA-University of Oviedo research group and the company Microviable Therapeutics, with Susana Delgado, from IPLA-CSIC, as the responsible researcher, has managed to identify and select bacteria in the microbiota [...]
Microviable will be presenting at Bio€quity Europe. San Sebastián
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). On Tuesday 14th [...]
Microviable signed an agreement with Deltalab for the distribution of GutAlive kit, designed for the collection and transport of microbiota.
Microviable Therapeutics has signed a collaboration agreement with the Healthcare & Lifescience division of Deltalab (member of SCGP) for the international distribution of GutAlive® kit for the collection and transport of microbiota. Thanks to [...]
Microviable will be attending Bio€quity Europe. San Sebastián
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). Microviable Team joins [...]
Past, present, and future of microbiome-based therapies
Technological advances in studying the human microbiome in depth have enabled the identification of microbial signatures associated with health and disease. This confirms the crucial role of microbiota in maintaining homeostasis and the host health [...]
Inmunobiota: A co-creation project of Microviable and the Institute of Catalysis and Petroleochemistry (ICP-CSIC)
Inmunobiota is one of the projects selected in CSIC-COCREA that seeks to develop products based on microbiota to combat infections and enhance the immune response. THE CHALLENGE Immunotherapy has improved the prognosis of lung cancer, [...]